Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nature's Sunshine Products, Inc. - Common Stock (NQ:NATR)

13.10 +0.54 (+4.34%)
Streaming Delayed Price Updated: 2:18 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nature's Sunshine Products, Inc. - Common Stock

< Previous 1 2 3 Next >
3 Small-Cap Stocks Skating on Thin Ice
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
3 Consumer Stocks in Hot Water
Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. But recently, the industry has failed to do its job as it shed 9.5% over the past six months.... 
Via StockStory
Topics Stocks
Exposures US Equities
Unpacking Q4 Earnings: BeautyHealth (NASDAQ:SKIN) In The Context Of Other Personal Care Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including BeautyHealth (NASDAQ:SKIN) and its peers. 
Via StockStory
Topics Economy
Exposures Economy
Q4 Earnings Highs And Lows: Coty (NYSE:COTY) Vs The Rest Of The Personal Care Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Coty (NYSE:COTY) and its peers. 
Via StockStory
Topics Economy
Exposures Economy
Nature's Sunshine (NASDAQ:NATR) Beats Q4 Sales Targets
Wellness products company Nature’s Sunshine (NASDAQ:NATR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 8.5% year on year to $118.2 million. The company expects... 
Via StockStory
Earnings Scheduled For March 11, 2025
Via Benzinga
Earnings To Watch: Nature's Sunshine (NATR) Reports Q4 Results Tomorrow
Wellness products company Nature’s Sunshine (NASDAQ:NATR) will be reporting earnings tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Nature's Sunshine (NATR): Buy, Sell, or Hold Post Q3 Earnings?
Nature's Sunshine currently trades at $14.37 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 16.9% gain during... 
Via StockStory
Topics Stocks
Exposures US Equities
Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
1 Consumer Stock to Hold Forever and 2 to Dump
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. On the other hand, they usually underperform during bull runs, but the sector has bucked this trend... 
Via StockStory
Topics Stocks
Exposures US Equities
Reflecting On Personal Care Stocks’ Q3 Earnings: Inter Parfums (NASDAQ:IPAR)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Inter Parfums (NASDAQ:IPAR) and... 
Via StockStory
Topics Economy
Exposures Economy
Spotting Winners: Nu Skin (NYSE:NUS) And Personal Care Stocks In Q3
Let’s dig into the relative performance of Nu Skin (NYSE:NUS) and its peers as we unravel the now-completed Q3 personal care earnings season. 
Via StockStory
Topics Economy
Exposures Economy
The Honest Company (NASDAQ:HNST) Q3 Earnings: Leading The Personal Care Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how The Honest Company... 
Via StockStory
Topics Economy
Exposures Economy
Personal Care Stocks Q3 Recap: Benchmarking Nature's Sunshine (NASDAQ:NATR)
Let’s dig into the relative performance of Nature's Sunshine (NASDAQ:NATR) and its peers as we unravel the now-completed Q3 personal care earnings season. 
Via StockStory
Topics Economy
Exposures Economy
Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with... 
Via StockStory
Topics Economy
Exposures Economy
Personal Care Stocks Q3 Teardown: Herbalife (NYSE:HLF) Vs The Rest
Looking back on personal care stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Herbalife (NYSE:HLF) and its peers. 
Via StockStory
Topics Economy
Exposures Economy
Personal Care Stocks Q3 Highlights: Coty (NYSE:COTY)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Coty... 
Via StockStory
Topics Economy
Exposures Economy
Q3 Rundown: Estée Lauder (NYSE:EL) Vs Other Personal Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Estée... 
Via StockStory
Topics Economy
Exposures Economy
Nature's Sunshine (NASDAQ:NATR) Surprises With Strong Q3, Full-Year Sales Guidance Is Optimistic
Wellness products company Nature’s Sunshine Products (NASDAQ:NATR) reported Q3 CY2024 results beating Wall Street’s revenue expectations, with sales up 3.1% year on year to $114.6 million. The... 
Via StockStory
Nature's Sunshine (NATR) Q3 Earnings Report Preview: What To Look For
Wellness products company Nature’s Sunshine Products (NASDAQ:NATR) will be reporting earnings tomorrow after market hours. Here’s what investors should know. 
Via StockStory
Nature's Sunshine To Gain From Margin Expansion - Analyst Projects 15% Adjusted EBITDA Margin By FY28
Analyst Susan Anderson projects Nature's Sunshine Products to achieve a 15% adjusted EBITDA margin by FY28, driven by digital growth, international expansion, and innovation. 
Via Benzinga
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Nature’s Sunshine Products to Present at the 2024 Gateway Conference on September 4th, 2024
From Nature's Sunshine Products, Inc.
Via GlobeNewswire
NATR Stock Earnings: Natures Sunshine Products Misses EPS, Misses Revenue for Q2 2024
NATR stock results show that Natures Sunshine Products missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
NATR Stock Earnings: Natures Sunshine Products Misses EPS, Misses Revenue for Q1 2024
NATR stock results show that Natures Sunshine Products missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Nature’s Sunshine Recognized with Six Stevie Awards in the 2024 American Business Awards
From Nature's Sunshine Products, Inc.
Via GlobeNewswire
What Is the Best $20 Stock to Buy in April? 3 Top Picks.
If you’re looking for the best $20 stocks to buy, you’ll want to scour the names of the Russell 2000 for inspiration. 
Via InvestorPlace
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.